Stay updated on Elotuzumab in Myeloma: VRD Induction Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab in Myeloma: VRD Induction Clinical Trial page.

Latest updates to the Elotuzumab in Myeloma: VRD Induction Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added and the government funding notice removed, both indicating administrative updates not affecting study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a government funding/operating-status notice and a new Revision: v3.4.1 entry. The previous Revision: v3.4.0 entry was removed.SummaryDifference0.8%

- Check28 days agoChange DetectedUI updates include a 'Show glossary' option, color-coded change highlights (green for additions and red for deletions), and a new revision label 'Revision: v3.4.0.' Minor capitalization changes to the 'No FEAR Act' label are also visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check64 days agoChange DetectedAdded Revision: v3.3.3 to the Record History. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check86 days agoChange DetectedThe study record history now includes a new revision entry (v3.3.2) and the previous revision (v3.3.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedThe record history now shows a new revision entry v3.3.1 and the v3.2.0 entry was removed.SummaryDifference0.1%

Stay in the know with updates to Elotuzumab in Myeloma: VRD Induction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab in Myeloma: VRD Induction Clinical Trial page.